Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2354850 | 0.97 | — | — | |
| SCHEMBL21747588 | 0.89 | — | — | |
| SCHEMBL135373 | 0.80 | ALDH1A1 (0.35) | — | |
| Ammonia Solution, Strong SCHEMBL9559498 | 0.78 | ALDH1A1 (0.33) | — | |
| Ammonia Solution, Strong SCHEMBL3735949 | 0.77 | — | — | |
| SCHEMBL295301 | 0.77 | — | — | |
| SCHEMBL4436655 | 0.77 | — | — | |
| SCHEMBL7929931 | 0.77 | — | — | |
| SCHEMBL114178 | 0.75 | ALDH1A1 (0.33) | — | |
| SCHEMBL8967132 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545809-B2 | Moisture-curing conformal coating compositions | WACKER CHEMIE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20250177301-A1 | TRIPLEX NANOPARTICLES | UNM RAINFOREST INNOVATIONS | 2025-06-05 | — | — | US | disclosed |
| EP-4172246-B1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-20230279263-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2023-09-07 | — | — | US | disclosed |
| WO-2023147596-A1 | TRIPLEX NANOPARTICLES | NOUREDDINE ACHRAF (US) | 2023-08-03 | — | — | WO | disclosed |
| US-11672866-B2 | Osteotropic nanoparticles for prevention or treatment of bone metastases | UNM RAINFOREST INNOVATIONS | 2023-06-13 | — | — | US | disclosed |
| EP-4172246-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | Wacker Chemie AG (DE) | 2023-05-03 | — | — | EP | disclosed |
| CN-115702188-A | Moisture-curable conformal coating composition | 瓦克化学股份公司 | 2023-02-14 | — | — | CN | disclosed |
| WO-2021259460-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2021-12-30 | — | — | WO | disclosed |
| US-20210030675-A1 | MESOPOROUS SILICA NANOPARTICLES AND SUPPORTED LIPID BI-LAYER NANOPARTICLES FOR BIOMEDICAL APPLICATIONS | BRINKER C JEFFREY (US) | 2021-02-04 | — | — | US | disclosed |
| WO-2013103614-A1 | CRLF-2 BINDING PEPTIDES, PROTOCELLS AND VIRAL-LIKE PARTICLES USEFUL IN THE TREATMENT OF CANCER, INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) | STC.UNM (US) | 2013-07-11 | — | — | WO | disclosed |
| WO-2013056132-A2 | POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF | STC.UNM (US) | 2013-04-18 | — | — | WO | disclosed |
| WO-2012149376-A2 | POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME | STC.UNM (US) | 2012-11-01 | — | — | WO | disclosed |
| EP-0197540-B1 | USE OF AMINES FOR STABILIZING POLYSILOXANE FLUIDS | WACKER-CHEMIE GMBH (DE) | 1991-11-13 | — | — | EP | disclosed |
| US-4933414-A | Radiation active silicon compounds having amide limited mercaptan functional groups | GENERAL ELECTRIC COMPANY (US) | 1990-06-12 | — | — | US | disclosed |
| US-4783490-A | Radiation active silicon compounds having amide limited mercaptan functional groups | GENERAL ELECTRIC COMPANY (US) | 1988-11-08 | — | — | US | disclosed |
| US-4644074-A | AGAINST DEGRADATION BY KAOLIN CLAY BY ADDING AN AMINE | SWS SILICONES CORPORATION (US) | 1987-02-17 | — | — | US | disclosed |
| EP-0197540-A2 | Use of amines for stabilizing polysiloxane fluids | WACKER-CHEMIE GMBH (DE) | 1986-10-15 | — | — | EP | disclosed |
| US-4612055-A | Stabilized blends of thiofunctional polysiloxane fluids and organopolysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-09-16 | — | — | US | disclosed |
| US-4588771-A | Stabilized thiofunctional polysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11672866-B2 | Osteotropic nanoparticles for prevention or treatment of bone metastases | SOST, ACP3, KLK3 | CYP2D6 3967/4885 |
| US-12545809-B2 | Moisture-curing conformal coating compositions | COL1A1, COL2A1, MSR1 | CYP2D6 3426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.